PHOENIXBIO CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 500 JPY | -0.40% |
|
-4.94% | +7.30% |
Valuation
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,093 | 1,646 | 2,026 | 1,733 | 2,235 | 1,942 |
| Enterprise Value (EV) 1 | 1,510 | 1,185 | 1,736 | 1,445 | 1,809 | 1,280 |
| P/E ratio | -7.03 x | -3.96 x | -8.37 x | -4.47 x | 6.32 x | 70.1 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.7 x | 1.26 x | 2 x | 1.31 x | 1.05 x | 1.13 x |
| EV / Revenue | 1.23 x | 0.9 x | 1.71 x | 1.09 x | 0.85 x | 0.75 x |
| EV / EBITDA | -6.04 x | -18.8 x | -7.82 x | -17.6 x | 3.4 x | 42.7 x |
| EV / FCF | -9.83 x | -64.1 x | -8.04 x | -32.1 x | 22 x | -6.3 x |
| FCF Yield | -10.2% | -1.56% | -12.4% | -3.11% | 4.55% | -15.9% |
| Price to Book | 1.36 x | 1.42 x | 1.85 x | 2.09 x | 1.48 x | 1.08 x |
| Nbr of stocks (in thousands) | 2,923 | 2,934 | 3,288 | 3,307 | 3,634 | 4,028 |
| Reference price 2 | 716.0 | 561.0 | 616.0 | 524.0 | 615.0 | 482.0 |
| Announcement Date | 6/28/19 | 6/26/20 | 6/25/21 | 6/29/22 | 6/28/23 | 6/27/24 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,228 | 1,310 | 1,013 | 1,324 | 2,124 | 1,715 |
| EBITDA 1 | -250 | -63 | -222 | -82 | 532 | 30 |
| EBIT 1 | -312 | -147 | -277 | -168 | 509 | 5 |
| Operating Margin | -25.41% | -11.22% | -27.34% | -12.69% | 23.96% | 0.29% |
| Earnings before Tax (EBT) 1 | -295 | -416 | -224 | -392 | 510 | 59 |
| Net income 1 | -297 | -415 | -238 | -387 | 493 | 26 |
| Net margin | -24.19% | -31.68% | -23.49% | -29.23% | 23.21% | 1.52% |
| EPS 2 | -101.8 | -141.6 | -73.60 | -117.2 | 97.29 | 6.875 |
| Free Cash Flow 1 | -153.6 | -18.5 | -215.8 | -45 | 82.25 | -203.1 |
| FCF margin | -12.51% | -1.41% | -21.3% | -3.4% | 3.87% | -11.84% |
| FCF Conversion (EBITDA) | - | - | - | - | 15.46% | - |
| FCF Conversion (Net income) | - | - | - | - | 16.68% | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 6/28/19 | 6/26/20 | 6/25/21 | 6/29/22 | 6/28/23 | 6/27/24 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2021 S1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2024 Q1 | 2024 S1 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 301 | 637 | 296 | 445 | 1,135 | 525 | 439 | 881 | 447 |
| EBITDA | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -288 | -133 | -39 | 89 | 367 | 97 | 7 | -5 | 35 |
| Operating Margin | -95.68% | -20.88% | -13.18% | 20% | 32.33% | 18.48% | 1.59% | -0.57% | 7.83% |
| Earnings before Tax (EBT) 1 | -265 | -128 | -30 | 113 | 403 | 43 | 47 | 63 | -14 |
| Net income 1 | -267 | -130 | -31 | 103 | 356 | 37 | 42 | 27 | -13 |
| Net margin | -88.7% | -20.41% | -10.47% | 23.15% | 31.37% | 7.05% | 9.57% | 3.06% | -2.91% |
| EPS 2 | -83.98 | -39.59 | -9.420 | 31.26 | 107.6 | 10.05 | 11.59 | 7.530 | -3.640 |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/13/20 | 11/12/21 | 2/14/22 | 8/12/22 | 11/14/22 | 2/14/23 | 8/14/23 | 11/14/23 | 2/14/24 |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 583 | 461 | 290 | 288 | 426 | 662 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -154 | -18.5 | -216 | -45 | 82.3 | -203 |
| ROE (net income / shareholders' equity) | -17.5% | -30.7% | -21.1% | -40.3% | 42.1% | 1.57% |
| ROA (Net income/ Total Assets) | -9.57% | -3.92% | -6.53% | -4.38% | 12% | 0.11% |
| Assets 1 | 3,103 | 10,590 | 3,643 | 8,838 | 4,105 | 23,853 |
| Book Value Per Share 2 | 528.0 | 396.0 | 332.0 | 250.0 | 417.0 | 446.0 |
| Cash Flow per Share 2 | 224.0 | 605.0 | 404.0 | 401.0 | 428.0 | 344.0 |
| Capex 1 | 64 | 30 | 181 | 6 | 7 | 31 |
| Capex / Sales | 5.21% | 2.29% | 17.87% | 0.45% | 0.33% | 1.81% |
| Announcement Date | 6/28/19 | 6/26/20 | 6/25/21 | 6/29/22 | 6/28/23 | 6/27/24 |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +7.30% | 12.75M | |
| +23.52% | 47.07B | |
| +46.45% | 42.06B | |
| -3.14% | 39.98B | |
| +37.40% | 33.02B | |
| -6.30% | 27.9B | |
| +19.53% | 27.63B | |
| +47.66% | 14.37B | |
| +44.42% | 13.45B | |
| +0.51% | 12.03B |
- Stock Market
- Equities
- 6190 Stock
- Financials PhoenixBio Co., Ltd.
